By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celyad (Formally Known as Cardio3 BioSciences) 

Parc de L’Alliance
9, Boulevard de France
Braine - L’Alleud    1420  Belgium
Phone: 32-2-790-35-30 Fax: 32-2-790-35-35


SEARCH JOBS


Industry
Biotechnology






Company News
Celyad Reports First Half 2015 Financial Results And Operational Progress 8/25/2015 7:12:03 AM
Celyad Announces Details Of Upcoming Half Year 2015 Financial Results 8/12/2015 12:29:54 PM
Celyad Completes Final Patient Infusion In CHART-1 Phase III Trial 8/3/2015 7:09:48 AM
Celyad Announces Closing of Its Global Offering 6/24/2015 10:49:06 AM
Celyad Scores $100.1 Million Gross Proceeds With NASDAQ IPO 6/19/2015 7:06:43 AM
Celyad Preps for $99 Million IPO 6/16/2015 7:32:34 AM
Celyad Completes 30-Day Safety Follow-Up Of First Patient In NKG2D Phase I Trial 6/11/2015 7:29:32 AM
Celyad Announces First Quarter 2015 Business Update 5/19/2015 10:50:58 AM
Celyad Says It Might Go Shopping With $115 Million IPO As CAR-T Roars 5/18/2015 1:20:19 PM
Cardio3 Biosciences Announces Results Of Annual Shareholder Assembly 2015 And Confirmation Of Name Change To Celyad 5/5/2015 10:27:15 AM
12345678
//-->